Výsledky vyhledávání

Associations of soluble fms-like tyrosine kinase-1 with cardiovascular events and stroke in patients with atrial fibrillation and suspected or known coronary artery disease: the EXCEED-J study

Autor: H Wada, T Shinozaki, M Suzuki, S Sakagami, Y Ajiro, J Funada, M Matsuda, M Shimizu, T Takenaka, Y Morita, K Wada, K Kotani, M Abe, M Akao, K Hasegawa

Publikováno v: European Heart Journal. 43

Background Atrial fibrillation (AF) increases the risk of stroke. Soluble fms-like tyrosine kinase-1 (sFlt-1), a vascular endothelial growth factor (VEGF) antagonist, has been suggested as a marker of endothelial dysfunction, which are associated wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b22ef9cd206be3a3802b3dc832d6a414
https://doi.org/10.1093/eurheartj/ehac544.544

Zobrazit plný text záznamu

Involvement of growth differentiation factor 15 in paradoxical relationship between body mass index and mortality in patients with suspected or known coronary artery disease; The ANOX Study

Autor: M Matsuda, M Suzuki, Y Ajiro, T Shinozaki, S Sakagami, K Yonezawa, M Shimizu, J Funada, T Takenaka, Y Morita, M Iguchi, M Abe, M Akao, K Hasegawa, H Wada

Publikováno v: European Heart Journal. 43

Background Obesity is a well-established risk factor for type 2 diabetes mellitus, hypertension and dyslipidemia, leading to coronary artery disease (CAD). Nevertheless, body mass index (BMI) is inversely associated with cardiovascular (CV) mortality

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::94ab3f95e3a88931e658e11a076b828f
https://doi.org/10.1093/eurheartj/ehac544.2391

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of glucose tolerance status on the relationship between vascular endothelial growth factor D and mortality in patients with suspected coronary artery disease: a subanalysis of the ANOX study

Autor: Mitsuru Abe, M Matsuda, Takashi Unoki, K Yonezawa, Tsuyoshi Shinozaki, Kazuhiko Kotani, Yoichi Ajiro, S Sakagami, J Funada, Masaharu Akao, T Takenaka, M Suzuki, Hiromichi Wada, Koji Hasegawa, M Shimizu

Publikováno v: European Heart Journal. 41

Background Vascular endothelial growth factor D (VEGF-D) is a secreted glycoprotein that can act as lymphangiogenic and angiogenic growth factors through binding to its specific receptors, VEGFR-3 and VEGFR-2. VEGF-D signaling via VEGFR-3 plays an im

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f4388e143a973fe72ac5cb18af5dfe6a
https://doi.org/10.1093/ehjci/ehaa946.3061

Zobrazit plný text záznamu

Impact of anemia on the relationship between vascular endothelial growth factor C and mortality in patients with suspected or known coronary artery disease: a subanalysis of the ANOX study

Autor: Masaharu Akao, Tsuyoshi Shinozaki, S Sakagami, Moritake Iguchi, K Yonezawa, Hiromichi Wada, Mitsuru Abe, M Suzuki, T Takenaka, M Shimizu, J Funada, Yoichi Ajiro, M Wada, M Matsuda, Koji Hasegawa

Publikováno v: European Heart Journal. 41

Background The lymphatic system has been suggested to play an important role in cholesterol metabolism and cardiovascular (CV) disease. Recently, we demonstrated that serum levels of vascular endothelial growth factor C (VEGF-C), a central player of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fec8a216b4e30b5f7632e1109997d93c
https://doi.org/10.1093/ehjci/ehaa946.1347

Zobrazit plný text záznamu

Impact of chronic kidney disease on the relationship between vascular endothelial growth factor C and mortality in patients with suspected coronary artery disease: a subanalysis of the ANOX study

Autor: Masaharu Akao, M Matsuda, D Takagi, Yoichi Ajiro, Tsuyoshi Shinozaki, K Wada, Koji Hasegawa, S Sakagami, Mitsuru Abe, Hiromichi Wada, T Takenaka, M Shimizu, M Suzuki, J Funada, K Yonezawa

Publikováno v: European Heart Journal. 41

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::400059f14332c60114c0afd3068718a7
https://doi.org/10.1093/ehjci/ehaa946.3321

Zobrazit plný text záznamu

P5507Growth differentiation factor-15 and mortality in suspected or known coronary heart disease patients with chronic kidney disease: a subanalysis of the ANOX study

Autor: K Yonezawa, Mitsuru Abe, Masaharu Akao, Tsuyoshi Shinozaki, D Takagi, Yoichi Ajiro, M Suzuki, Y Morita, Koji Hasegawa, M Matsuda, Hiromichi Wada, J Funada, M Shimizu, S Sakagami, T Takenaka

Publikováno v: European Heart Journal. 40

Background Chronic kidney disease (CKD) is an independent risk factor for the development and progression of coronary heart disease (CHD). Growth differentiation factor-15 (GDF-15), a distant member of the transforming growth factor-β cytokine super

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bfdb17f7e72e1886a1b89b2e69ba488e
https://doi.org/10.1093/eurheartj/ehz746.0457

Zobrazit plný text záznamu

P1645Vascular endothelial growth factor-D and mortality in suspected or known coronary heart disease patients with a history of heart failure: a subanalysis of the ANOX study

Autor: Tsuyoshi Shinozaki, M Matsuda, J Funada, Moritake Iguchi, Hiromichi Wada, M Wada, T Takenaka, Masaharu Akao, K Yonazawa, S Sakagami, Yoichi Ajiro, M Shimizu, Koji Hasegawa, M Suzuki, Mitsuru Abe

Publikováno v: European Heart Journal. 40

Background Vascular endothelial growth factor-D (VEGF-D) is a secreted glycoprotein that can act as lymphangiogenic and angiogenic growth factors through binding to its specific receptors, VEGFR-3 (Flt-4) and VEGFR-2 (KDR/Flk-1). VEGF-D signaling via

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::66a3e803036ad55ff102cd09257c89cc
https://doi.org/10.1093/eurheartj/ehz748.0404

Zobrazit plný text záznamu

P5526Vascular endothelial growth factor-D and mortality in suspected or known coronary heart disease patients with chronic kidney disease: a subanalysis of the ANOX study

Autor: M Wada, J Funada, Tsuyoshi Shinozaki, T Takenaka, S Sakagami, K Yonezawa, M Matsuda, Koji Hasegawa, Masaharu Akao, Mitsuru Abe, Y Morita, Hiromichi Wada, M Suzuki, Yoichi Ajiro, M Shimizu

Publikováno v: European Heart Journal. 40

Background Chronic kidney disease (CKD) is an independent risk factor for the development and progression of coronary heart disease (CHD). Vascular endothelial growth factor-D (VEGF-D) is a secreted glycoprotein that can act as lymphangiogenic and an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8c2fd4db0baa3fb5af04cff7b0b06ba5
https://doi.org/10.1093/eurheartj/ehz746.0474

Zobrazit plný text záznamu

P3639Vascular endothelial growth factor-C and mortality in patients with suspected but no history of coronary heart disease: a subanalysis of the ANOX study

Autor: T Unoki, M Suzuki, M Matsuda, Y Ajiro, T Shinozaki, S Sakagami, K Yonezawa, M Shimizu, J Funada, T Takenaka, K Wada, M Abe, M Akao, K Hasegawa, H Wada

Publikováno v: European Heart Journal. 40

Background The lymphatic system has been suggested to play an important role in cholesterol metabolism and cardiovascular disease. Recently, we demonstrated that serum levels of vascular endothelial growth factor-C (VEGF-C), a central player of lymph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::340975ea3ca7a5cc94a33ffea2481930
https://doi.org/10.1093/eurheartj/ehz745.0496

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání